{
    "2019-10-23": [
        [
            {
                "time": "2018-10-23",
                "original_text": "Two Drugmakers Beat Earnings Forecasts — So Why Did One Topple?",
                "features": {
                    "keywords": [
                        "earnings",
                        "beat",
                        "forecasts",
                        "topple"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-24",
                "original_text": "Boeing, Caterpillar report disappointing earnings, but their shares bounce back",
                "features": {
                    "keywords": [
                        "disappointing",
                        "earnings",
                        "bounce back"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrials",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly to target cancer drug developers for deals",
                "features": {
                    "keywords": [
                        "Lilly",
                        "cancer",
                        "drug",
                        "deals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Q3",
                        "earnings",
                        "top",
                        "sales lag",
                        "stock down"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly Earned More Than Expected. Here’s Why the Stock Is Falling Anyway.",
                "features": {
                    "keywords": [
                        "Lilly",
                        "earned",
                        "expected",
                        "stock falling"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly (LLY) Surpasses Q3 Earnings Estimates",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Q3",
                        "earnings",
                        "surpasses"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly Reports Mixed Q3 Earnings, Raises Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "mixed",
                        "earnings",
                        "raises guidance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly, Alexion Earnings Top Q3 Views, But Stocks Diverge",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Alexion",
                        "earnings",
                        "top",
                        "stocks diverge"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly raises earnings guidance as new drugs boost sales",
                "features": {
                    "keywords": [
                        "Lilly",
                        "raises",
                        "guidance",
                        "new drugs",
                        "boost sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly tops profit estimates in latest quarter as revenue falls short",
                "features": {
                    "keywords": [
                        "Lilly",
                        "profit",
                        "estimates",
                        "revenue falls short"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "UPDATE 4-Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Trulicity",
                        "sales fall short",
                        "shares drop"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Trulicity",
                        "sales fall short",
                        "shares drop"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly reports 9% rise in third-quarter profit",
                "features": {
                    "keywords": [
                        "Lilly",
                        "profit",
                        "rise"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly misses sales estimates as top-seller Trulicity disappoints",
                "features": {
                    "keywords": [
                        "Lilly",
                        "misses",
                        "sales estimates",
                        "Trulicity"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "strong",
                        "financial results",
                        "EPS guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno",
                "features": {
                    "keywords": [
                        "Conterno",
                        "retire",
                        "Mason",
                        "succeed"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Eli Lilly Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Q3",
                        "earnings forecast",
                        "boosts",
                        "profit guidance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "Stocks - Caterpillar, Eli Lilly, Texas Instruments Fall Premarket; Boeing Rises",
                "features": {
                    "keywords": [
                        "Caterpillar",
                        "Lilly",
                        "Texas Instruments",
                        "fall",
                        "Boeing rises"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrials",
                        "pharmaceuticals",
                        "semiconductors",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}